EUVIMEDEUVIMED entdecken
Crossref

Postbiotics as Modulators of Apoptotic and Metastatic Pathways in Colorectal Cancer: Insights from HT-29 Cell Responses

Hiva safaei

Life Sciences Student Journal · 06.12.2025

DOI: 10.22034/lssj.2025.170 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Life Sciences Student Journal, erschienen am 06.12.2025. Verfasst von Hiva safaei.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Colorectal cancer is one of the leading causes of cancer-related morbidity and mortality worldwide, and its incidence is strongly influenced by diet, lifestyle, chronic inflammation, and the composition of the gut microbiota.[1–4] Increasing evidence suggests that microbial dysbiosis contributes to tumor initiation and progression through altered metabolite production, impaired barrier function, and activation of oncogenic signaling pathways such as Wnt/β-catenin, NF-κB, MAPK/ERK, and STAT3.[3,5,6,14,19] In parallel, interest has grown in microbiota-centered interventions, particularly probiotics, prebiotics, synbiotics, and more recently postbiotics, which are defined as non-viable microbial cells, components, or metabolites that exert health-promoting effects in the host.[3,7–10] Postbiotics are attractive because they are stable, safe for immunocompromised patients, and easier to standardize than live probiotics, while still retaining potent immunomodulatory, anti-inflammatory, and anticancer activities.[7–13,21,26] Experimental and review data indicate that postbiotics can inhibit CRC cell growth, induce apoptosis, modulate the cell cycle, and regulate metastasis-associated genes and pathways, including RSPO2, NGF, MMP7, and mitochondrial apoptosis regulators such as Bax, Bcl-2, and caspase-3.[10–13,16,17,20] In particular, postbiotics derived from Bifidobacterium breve and Lactobacillus rhamnosus have shown promising effects in HT-29 colorectal cancer cells, where they promote apoptosis and attenuate pro-metastatic gene expression.[10,20] This review summarizes current knowledge on the relationship between the gut microbiota and CRC, defines and contextualizes postbiotics, explores their molecular mechanisms in carcinogenesis with a focus on CRC, and discusses the translational and clinical potential of postbiotics as complementary tools in CRC prevention and management.[3,7,11–13,18,26–28]

Schlagwörter

postbioticscolorectal cancerapoptosismetastasisgut microbiotaHT-29 cellsBifidobacterium breveLactobacillus rhamnosusmicrobial metabolitescarcinogenesis

Zitieren

APA

safaei, H. (2025). Postbiotics as Modulators of Apoptotic and Metastatic Pathways in Colorectal Cancer: Insights from HT-29 Cell Responses. Life Sciences Student Journal. https://doi.org/10.22034/lssj.2025.170

Vancouver

safaei H. Postbiotics as Modulators of Apoptotic and Metastatic Pathways in Colorectal Cancer: Insights from HT-29 Cell Responses. Life Sciences Student Journal. 2025. doi:10.22034/lssj.2025.170

BibTeX
@article{safaei2025,
  author = {safaei, Hiva},
  title = {Postbiotics as Modulators of Apoptotic and Metastatic Pathways in Colorectal Cancer: Insights from HT-29 Cell Responses},
  journal = {Life Sciences Student Journal},
  year = {2025},
  doi = {10.22034/lssj.2025.170}
}
Kostenlos starten →